MALAT1 and breast cancer: In contrast, eNEMAL was upregulated in response to hypoxia all other cancer cell lines (Fig 4A), demonstrating that this enhancer is hypoxic-responsive in breast cancer and its upregulation under hypoxia corresponds with that of MALAT1.